- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
What We're Reading: MSKCC AI Startup; AMA and Patient Privacy; GOP Healthcare Message
An artificial intelligence startup with ties to employees and board members of Memorial Sloan Kettering Cancer Center is sparking dissent at the venerable institution; the American Medical Association (AMA) is opposing a change to patient privacy laws contained in a massive opioids bill; Republicans are struggling to find a healthcare message to sell to voters as the midterm elections draw near.
MSKCC Staff Upset at Startup That Uses Doctors' Work, Patient Data
An artificial intelligence startup with ties to employees and board members of Memorial Sloan Kettering Cancer Center is sparking dissent at the venerable institution, especially in the wake of the resignation of its chief medical officer after it was found he failed to disclose financial relationships with industry in published articles. The startup, Paige.AI, has an exclusive deal to use the cancer center’s archive of 25 million patient tissue slides, ProPublica and The New York Times reported. Hospital pathologists are opposed to the idea, saying the founders are receiving equity stakes in a firm that is relying on their own scientific expertise, and they also question the use of patient data, even if it anonymous.
AMA Opposed to Loss of Patient Privacy in Opioid Bill
The American Medical Association (AMA) is opposing a change to patient privacy laws contained in a massive opioids bill that would allow doctors to more freely share information about a patient’s history of substance use disorders (SUD), STAT reported. The provision would allow the sharing of a full medical history, including SUD treatment, with other healthcare professionals and even insurers, sometimes without a patient’s consent. Currently, patients must agree to such sharing. The proposal that has divided the healthcare community, with the American Hospital Association and insurers supporting the idea, and it has highlighted some of the challenges of addressing the opioid epidemic.
Republicans Search for Healthcare Message They Can Use in Midterm Elections
Republicans are struggling to find a healthcare message to sell to voters as the midterm elections draw near, Politico reported. The GOP is trying to assuage fears about the possible loss of pre-existing conditions enshrined in the Affordable Care Act, but the most direct effort to address that issue, a recent Senate bill Republicans said would protect sick patients, backfired when it was found to contain loopholes. Also working against Republicans: the Trump administration's support for a lawsuit in Texas that would gut the healthcare law.
Mental Health Diagnoses, Care Challenges Rise Among US Youth, Report Finds
April 26th 2024While behavioral health care utilization has been rising, the treatment landscape has been falling. New findings show that 20% of youths did not receive any form of treatment within 3 months of their initial behavioral health diagnosis.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Males With Hemophilia A Report Physical, Mental Burdens of Disease Regardless of Severity
April 25th 2024Self-reported data from adult and pediatric males with hemophilia A show that burden of the disease persists regardless of severity, highlighting a need for improved prophylactic treatment.
Read More
Insurance Coverage Limits JAKi Therapy Access for Patients With AA, Especially Non-White Populations
April 25th 2024A survey study showed major barriers to Janus kinase inhibitor (JAKi) therapy for patients with alopecia areata, especially for non-White patients who face higher rates of being uninsured and struggle more to afford the treatment.
Read More
